OPTIMIZING OXYGENATION: UNVEILING THE POTENTIAL OF INHALED NITRIC OXIDE IN THE MANAGEMENT OF EISENMENGER SYNDROME
Keywords:
Abstract
Eisenmenger Syndrome poses a complex challenge in the realm of congenital heart diseases, characterized by pulmonary hypertension and shunting of blood. This paper delves into the potential of inhaled nitric oxide (iNO) as a therapeutic intervention for optimizing oxygenation in individuals with Eisenmenger Syndrome. Through a comprehensive review of existing literature, clinical studies, and case reports, this research explores the physiological mechanisms, safety profile, and efficacy of iNO in ameliorating hypoxemia and pulmonary vascular resistance associated with Eisenmenger Syndrome. The findings aim to contribute valuable insights to the evolving landscape of treatment options for this rare and intricate cardiovascular condition.
Similar Articles
-
Role And Significance Of Kisspeptin In The Female Reproductive System
The American Journal of Medical Sciences and Pharmaceutical Research: No. 04 (2021) / F.A.Xaydarova, N.M. Baqoyeva , Y.X.Turakulov , -
Some Structural Features Of The Prevalence Of Disability And Kaitian Disability In Khorezm Province From Hypertension
The American Journal of Medical Sciences and Pharmaceutical Research: No. 09 (2021) / Ruzmetov Bazirgon Shokirovich, -
Clinical And Functional Changes In Hard Tissues Of Teeth In Patients With Hemophilia
The American Journal of Medical Sciences and Pharmaceutical Research: No. 12 (2020) / Alisher Berdikulovich Norbutaev, Mukhiddin Kamariddinovich Shamsiev, Nodira Sharipovna Nazarova , -
Features Of The Use Of Antioxidant Drugs In The Treatment Of Psoriatic Disease
The American Journal of Medical Sciences and Pharmaceutical Research: No. 02 (2021) / Akhmedov Shavkat Kurbonalievich , Oripov Rustam Anvarovich , Ashirov Zohijon Fayozjonovich , Nuralieva Rano Matyakubovna , Haydarov Musomiddin Mukhammadievich, -
State Of Purine Exchange And Microalbuminuria In Patients With Metabolic Syndrome
The American Journal of Medical Sciences and Pharmaceutical Research: No. 01 (2021) / Irodakhon Makhkambaevna Tashtemirova , -
The State Of The Prostacycline-Thromboxane System In Patients With Ischemic Heart Disease
The American Journal of Medical Sciences and Pharmaceutical Research: No. 07 (2020) / Khattahanova Rabiya Yuldashevna,, -
Clinical And Electro-Neuromyographic Changes In The Pathology Of The Muscular System In Patients With Hemophilia
The American Journal of Medical Sciences and Pharmaceutical Research: No. 11 (2020) / Madasheva Anazhan Gazkhanovna , Mamatkulova Feruza Khaidarovna, Uralov Rustam Sherbek Ugli, -
IMPROVING THE SYSTEM OF EPIDEMIOLOGICAL SURVEILLANCE OF INFECTIOUS DISEASES IN UZBEKISTAN
The American Journal of Medical Sciences and Pharmaceutical Research: No. 02 (2023) / Ikramov Rustamjon Niyozovich, -
Epidemiology, Risk Factors, Clinical-Imaging Features And Priorities For The Prevention Of Esophageal Cancer In The Fergana Valley Of Uzbekistan
The American Journal of Medical Sciences and Pharmaceutical Research: No. 01 (2021) / Azizbek Zulunov , Dilfuzahon Mamarasulova , Nematjon Mamasaliev, -
Results Of Examination Of Patients With Radiculopathies In Chronic Brucellosis
The American Journal of Medical Sciences and Pharmaceutical Research: No. 10 (2020) / Sokhiba Khakimova Ziyadullayevna, , Dildora Atokhodjaeva Alisherovna ,
References
Steudel W, Hurford E. WE, Zapol WM (1999) Inhaled nitric oxide:Basic biology and clinical applications. Anesthesiology 91(4):1090–121.
Anas M, Triastuti N, Airlangga MP (2020) Role of Inhaled Nitric Oxides In Pregnancy With Eisenmenger Syndrome. Qanun Med J Fac Med Muhammadiyah Surabaya 4(1):11–26.
Anggard E (1994)Nitric Oxide: mediator, murderer, and medicine. Lancet 343:1199–206.
Atz AM, Wessel DL (1997) Inhaled nitric oxide in the neonate with cardiac disease. Semin Perinatol 21(5):441–55.
Chen C (1997) Nitric Oxide For Newborns Nitric Oxide Proves Effective In Treating Newborns With Life-Threatening Lung Disorder [Internet]. Available from: cwchen@ITSA.UCSF.EDU
Finer NN, Barrington KJ (1997) Nitric oxide in respiratory failure in the newborn infant. In: Seminars in Perinatology. Elsevier, p. 426–40.
Barrington KJ, Finer N, Pennaforte T, Altit G (2017) Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. 2017(1): 1-9.
Smith C (1984) Congenital heart disease, with special reference to the indications and. In: Hahnemann monthly. 6th Editon. Appleton & Lange, p. 208–14.
Vaishnava H (1957) Heart diseases in pregnancy. InJournal of the Indian Medical Association, 6th Editon. Appleton & Lange, p. 228–33.
Barry AP, Meagher D, O’dwyer E (1956) Heart disease in pregnancy. In: Journal of the Irish Medical Association. 8th Editio. McGraw-Hill, Inc., p. 82–3.
Brennan K, Hatch DM (2018) Eisenmenger’s Syndrome. In: Consults in Obstetric Anesthesiology. Switzerland: Springer Nature, p. 185–7.
Gibbs CP (1988) Anesthetic Management of High-Risk Mother. In: Sciarra Gynecology and Obstetrics. J. B. Lippincott Company, p. 1–11.
